Analysis of glaucoma-related mortality in the united states using death certificate data

Journal of Glaucoma

Volumn 17, Issue 6, 2008, Pages 474-479

  Bennion, Jonathan R ^a,d   Wise, Matthew E ^a,b   Carver, John A ^c   Sorvillo, Frank ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Epidemiology; Glaucoma; Mortality; Multiple cause of death

Indexed keywords

ACCIDENT; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASTHMA; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHILD; COMORBIDITY; DEATH CERTIFICATE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GLAUCOMA; HEART DISEASE; HISPANIC; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; MORBIDITY; MORTALITY; NEGRO; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE; SCHOOL CHILD; SEX DIFFERENCE; SYSTEMIC DISEASE; UNITED STATES; ETHNOLOGY; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH CERTIFICATES; FEMALE; GLAUCOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NATIONAL CENTER FOR HEALTH STATISTICS (U.S.); SEX DISTRIBUTION; UNITED STATES;

EID: 58149123108     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318163bdbd     Document Type: Article

References (49)

1. Bennet G. Mortality rates in glaucomatous subjects. Arch Ophthalmol. 1955;54:637-640.
2. Ritland JS, Egge K, Lydersen S, et al. Comparison of survival of exfoliative glaucoma patients and primary open-angle glaucoma patients: impact of acetazolamide use. Acta Ophthalmol Scand. 2004; 82:397-400.
3. Ritland JS, Egge K, Lydersen S, et al. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand. 2004;82:401-404.
4. Lee DJ, Gómez-Marín O, Lam BL, et al. Glaucoma and survival: The National Health Interview Survey 1986-1994. Ophthalmology. 2003;110:1476-1483.
5. Hiller R, Podgor MJ, Sperduto RD, et al. High intraocular pressure and survival: the Framingham Studies. Am J Ophthalmol. 1999;128: 440-445.
6. Egge K, Zahl P-H. Survival of glaucoma patients. Acta Ophthalmol Scand. 1999;77:397-401.
7. Thorburn W, Lindblom B. Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol. 1983;61: 728-730.
8. Rogot E, Goldberg ID, Goldstein H. Survivorship and causes of death among the blind. J Chron Dis. 1966;19:179-197.
9. Grodum K, Heijl A, Bengtsson B. Glaucoma and mortality. Graefe's Arch Clin Exp Ophthalmol. 2004;242:397-401.
10. Borger PH, Van Leeuwen R, Hulsman CA, et al. Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology. 2003;110:1292-1296.
11. Klein R, Klein BE, Moss SE. Age-related eye disease and survival: the Beaver Dam Eye Study. Arch Ophthalmol. 1995;113:333-339.
12. Knudtson MD, Klein BE, Klein R. Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol. 2006;124:243-249.
13. Leske MC. Glaucoma and mortality: a connection? Ophthalmology. 2003;110:1473-1475.
14. Diggory P, Franks W. Medical treatment of glaucoma - a reappraisal of the risks. Br J Ophthalmol. 1996;80:85-89.
15. Lee AJ, Wang JJ, Kifley A, et al. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology. 2006;113:1069-1076.
16. Mastropasqua L, Carpineto P, Ciancaglini M, et al. Long-term results of Krupin-Denver valve implants in filtering surgery for neovascular glaucoma. Ophthalmologica. 1996;210:203-206.
17. Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer's disease at death: case-control study. Neurology. 1986;36:209-211.
18. Wise ME, Sorvillo F. Hepatitis A-related mortality in California, 1989-2000: analysis of multiple cause-coded death data. Am J Public Health. 2005;95:900-905.
19. McCoy L, Redelings M, Sorvillo F, et al. A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J Asthma. 2005;42:757-763.
20. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
21. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
22. National Center for Health Statistics (1997-2006). Data file documentations, multiple cause-of-death, 1990-2003 (Machine Readable Data File and Documentation, CD-ROM Series 20), National Center for Health Statistics; Hyattsville, Maryland.
23. Coleman AL. Glaucoma. Lancet. 1999;354:1803-1810.
24. National Center for Health Statistics. Bridged-race intercensal estimates of the July 1, 1990-July 1, 1999, United States resident population by county, single-year of age, sex, race, and Hispanic origin, prepared by the U.S. Census Bureau with support from the National Cancer Institute. Available on the Internet at: http://www.cdc.gov/nchs/about/major/dvs/popbridge/popbridge.htm. April 24, 2004.
25. National Center for Health Statistics. Estimates of the July 1, 2000-July 1, 2004, United States resident population from the Vintage 2004 postcensal series by year, county, age, sex, race, and Hispanic origin, prepared under a collaborative arrangement with the U.S. Census Bureau. Available on the Internet at: http://www.cdc.gov/ nchs/about/major/dvs/popbridge/popbridge.htm. September 9, 2005.
26. Anderson RN, Rosenberg HM. Age Standardization of Death Rates: Implementation of the Year 2000 Standard. National Vital Statistics Reports. Vol 47, No. 3. Hyattsville, Maryland: National Center for Health Statistics; 1998.
27. Fraunfelder FT. Ocular β-blockers and systemic effects. Arch Intern Med. 1986;146:1073-1074.
28. Britman NA. Cardiac effects of topical timolol. N Engl J Med. 1979; 300:566.
29. Diggory P, Franks WA. Glaucoma therapy may take your breath away. Age Ageing. 1997;26:63-67.
30. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project. JAMA. 1998;280:623-629.
31. Seddon JM, Schwartz B, Flowerdew G. Case-Control Study of Ocular Hypertension. Arch Ophthalmol. 1983;101:891-894.
32. Leske MC, Podgor MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol. 1983;118: 280-287.
33. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
34. Miglior S, Torri V, Zeyen T, et al. Intercurrent factors associated with the development of open-angle glaucoma in The European Glaucoma Prevention Study. Am J Ophthalmol. 2007;144:266-275.
35. Yablonski ME. An analysis of the "vascular hypothesis" concerning optic disc pathology in glaucoma. Ann Ophthalmol. 1979;11:67-69.
36. Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. Br Med J. 1985;291:93-95.
37. Hennis A, Wu S-Y, Nemesure B, et al. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology. 2003; 110:908-914.
38. Becker B. Diabetes mellitus and primary open-angle glaucoma: The XXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1971;71:1-16.
39. Clark CV, Mapstone R. The prevalence of diabetes mellitus in the family history of patients with primary glaucoma. Doc Ophthalmol. 1986;62:161-163.
40. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol. 2002;47: 165-168.
41. Bayer AU, Keller ON, Ferrari F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002;133: 135-137.
42. Vickers JC. The cellular mechanism underlying neuronal degeneration in glaucoma: parallels with Alzheimer's disease. Aust NZ J Ophthalmol. 1997;25:105-109.
43. Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection, and retinal ganglion cell death: an overview. Int Ophthalmol Clin. 2001; 41:111-130.
44. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
45. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore Eye Survey. JAMA. 1991;266:369-374.
46. Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol. 1996;7:93-98.
47. Wadhwa SD, Higginbotham EJ. Ethnic differences in glaucoma: prevalence, management, and outcome. Curr Opin Ophthalmol. 2005;16:101-106.
48. Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: The Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1439-1448.
49. Pritt BS, Hardin NJ, Richmond JA, et al. Death certification errors at an academic institution. Arch Pathol Lab Med. 2005;129: 1476-1479.